National Bank of Canada’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$155K Sell
4,025
-3,250
-45% -$134K ﹤0.01% 1682
2025
Q4
$299K Buy
+7,275
New +$287K ﹤0.01% 1489

Other funds holding BME

National Bank of Canada's BME Position: Q1 2026 in Review

National Bank of Canada reduced its BlackRock Health Sciences Trust (BME) stake by 45% in Q1 2026, selling an estimated $134K and leaving 4,025 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

National Bank of Canada first reported a position in BME in Q4 2025 and has held it in 2 quarters since. The position peaked at $299K in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • National Bank of Canada held 4,025 shares of BlackRock Health Sciences Trust worth $155K as of Q1 2026.
  • National Bank of Canada sold 3,250 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $134K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1682 holding.
  • National Bank of Canada first reported a position in BlackRock Health Sciences Trust in Q4 2025 and has held it in 2 quarters since.
  • National Bank of Canada's BlackRock Health Sciences Trust position peaked at $299K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.